Clinical Endoscopy

  • 제57권2호
  • /
  • Pages.141-157
  • /
  • 2024
  • /
  • 2234-2400(pISSN)
  • /
  • 2234-2443(eISSN)
대한소화기내시경학회 (The Korean Society of Gastrointestinal Endoscopy)
권호 표지
DOI QR코드

DOI QR Code

International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy

  • Seung Joo Kang (Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center) ;
  • Chung Hyun Tae (Department of Internal Medicine, Ewha Womans University College of Medicine) ;
  • Chang Seok Bang (Department of Internal Medicine, Hallym University College of Medicine) ;
  • Cheol Min Shin (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Young-Hoon Jeong (CAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Department of Internal Medicine, Chung-Ang University College of Medicine) ;
  • Miyoung Choi (National Evidence-Based Healthcare Collaborating Agency) ;
  • Joo Ha Hwang (Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University) ;
  • Yutaka Saito (Endoscopy Division, National Cancer Center Hospital) ;
  • Philip Wai Yan Chiu (Division of Upper GI and Metabolic Surgery, Department of Surgery, The Chinese University of Hong Kong) ;
  • Rungsun Rerknimitr (Division of Gastroenterology, Department of Medicine, Chulalongkorn University) ;
  • Christopher Khor (Department of Gastroenterology and Hepatology, Singapore General Hospital and Duke-NUS Medical School) ;
  • Vu Van Khien (Departments of GI Endoscopy, 108 Central Hospital) ;
  • Kee Don Choi (Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ki-Nam Shim (Department of Internal Medicine, Ewha Womans University College of Medicine) ;
  • Geun Am Song (Department of Internal Medicine, Pusan National University Hospital, Pusan National University College of Medicine and Biomedical Research Institute) ;
  • Oh Young Lee (Department of Internal Medicine, Hanyang University School of Medicine)
  • 투고 : 2023.12.28
  • 심사 : 2024.02.09
  • 발행 : 2024.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Antithrombotic agents, including antiplatelet agents and anticoagulants, are widely used in Korea because of the increasing incidence of cardiocerebrovascular disease and the aging population. The management of patients using antithrombotic agents during endoscopic procedures is an important clinical challenge. The clinical practice guidelines for this issue, developed by the Korean Society of Gastrointestinal Endoscopy, were published in 2020. However, new evidence on the use of dual antiplatelet therapy and direct anticoagulant management has emerged, and revised guidelines have been issued in the United States and Europe. Accordingly, the previous guidelines were revised. Cardiologists were part of the group that developed the guideline, and the recommendations went through a consensus-reaching process among international experts. This guideline presents 14 recommendations made based on the Grading of Recommendations, Assessment, Development, and Evaluation methodology and was reviewed by multidisciplinary experts. These guidelines provide useful information that can assist endoscopists in the management of patients receiving antithrombotic agents who require diagnostic and elective therapeutic endoscopy. It will be revised as necessary to cover changes in technology, evidence, or other aspects of clinical practice.

키워드

과제정보

We thank the executive members of the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Cardiology, the Korean Neurological Association, the Korean Society of Gastroenterology, the Korean College of Helicobacter and Upper Gastrointestinal Research, the Korean Association for the Study of Intestinal Disease, and the Korean Pancreatobiliary Association for reviewing the manuscript and providing expert opinions.

참고문헌

  1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. https://doi.org/10.1136/bmj.324.7329.71
  2. Joy M, Williams J, Emanuel S, et al. Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019). Heart 2023;109:195-201.
  3. Han J, Lee DW, Kim HG. Recent advances in endoscopic papillectomy for ampulla of vater tumors: endoscopic ultrasonography, intraductal ultrasonography, and pancreatic stent placement. Clin Endosc 2015;48:24-30. https://doi.org/10.5946/ce.2015.48.1.24
  4. Nabi Z, Reddy DN. Endoscopic palliation for biliary and pancreatic malignancies: recent advances. Clin Endosc 2019;52:226-234. https://doi.org/10.5946/ce.2019.003
  5. Gotoda T, Hori K, Iwamuro M, et al. Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection. Endosc Int Open 2017;5:E653-E662. https://doi.org/10.1055/s-0043-110050
  6. ASGE Standards of Practice Committee, Acosta RD, Abraham NS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc 2016;83:3-16. https://doi.org/10.1016/j.gie.2015.09.035
  7. Abraham NS, Barkun AN, Sauer BG, et al. American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. Am J Gastroenterol 2022;117:542-558. https://doi.org/10.14309/ajg.0000000000001627
  8. Veitch AM, Radaelli F, Alikhan R, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Endoscopy 2021;53:947-969. https://doi.org/10.1055/a-1547-2282
  9. Chan FKL, Goh KL, Reddy N, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut 2018;67:405-417. https://doi.org/10.1136/gutjnl-2017-315131
  10. Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc 2014;26:1-14. https://doi.org/10.1111/den.12183
  11. Lim H, Gong EJ, Min BH, et al. Clinical practice guideline for the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy. Clin Endosc 2020;53:663-677. https://doi.org/10.5946/ce.2020.192
  12. Cumpston MS, McKenzie JE, Welch VA, et al. Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition. J Public Health (Oxf) 2022;44:e588-e592. https://doi.org/10.1093/pubmed/fdac036
  13. Guyatt GH, Oxman AD, Kunz R, et al. Incorporating considerations of resources use into grading recommendations. BMJ 2008;336:1170-1173. https://doi.org/10.1136/bmj.39504.506319.80
  14. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
  15. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
  16. Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.
  17. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.
  18. Heise C, Abou Ali E, Hasenclever D, et al. Systematic review with meta-analysis: endoscopic and surgical resection for ampullary lesions. J Clin Med 2020;9:3622.
  19. Espinel J, Pinedo E, Ojeda V, et al. Endoscopic ampullectomy: a technical review. Rev Esp Enferm Dig 2016;108:271-278. https://doi.org/10.17235/reed.2016.3867/2015
  20. Wu CC, Lim SJ, Khor CJ, et al. Endoscopic retrograde cholangiopancreatography-related complications: risk stratification, prevention, and management. Clin Endosc 2023;56:433-445. https://doi.org/10.5946/ce.2023.013
  21. Takamaru H, Saito Y, Hammoud GM, et al. Comparison of postpolypectomy bleeding events between cold snare polypectomy and hot snare polypectomy for small colorectal lesions: a large-scale propensity score-matched analysis. Gastrointest Endosc 2022;95:982-989. https://doi.org/10.1016/j.gie.2021.12.017
  22. Kawamura T, Takeuchi Y, Asai S, et al. A comparison of the resection rate for cold and hot snare polypectomy for 4-9 mm colorectal polyps: a multicentre randomised controlled trial (CRESCENT study). Gut 2018;67:1950-1957. https://doi.org/10.1136/gutjnl-2017-314215
  23. Horiuchi A, Nakayama Y, Kajiyama M, et al. Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomy. Gastrointest Endosc 2014;79:417-423. https://doi.org/10.1016/j.gie.2013.08.040
  24. Giri S, Jearth V, Darak H, et al. Outcomes of thin versus thick-wire snares for cold snare polypectomy: a systematic review and meta-analysis. Clin Endosc 2022;55:742-750. https://doi.org/10.5946/ce.2022.141
  25. Tokuhara M, Shimatani M, Tominaga K, et al. Evaluation of a new method, "non-injection resection using bipolar soft coagulation mode (NIRBS)", for colonic adenomatous lesions. Clin Endosc 2023;56:623-632.
  26. Vleugels JL, Hazewinkel Y, Fockens P, et al. Natural history of diminutive and small colorectal polyps: a systematic literature review. Gastrointest Endosc 2017;85:1169-1176. https://doi.org/10.1016/j.gie.2016.12.014
  27. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention, 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/ AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA Guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 2016;134:e123-e155.
  28. Egholm G, Kristensen SD, Thim T, et al. Risk associated with surgery within 12 months after coronary drug-eluting stent implantation. J Am Coll Cardiol 2016;68:2622-2632. https://doi.org/10.1016/j.jacc.2016.09.967
  29. Hawn MT, Graham LA, Richman JS, et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013;310:1462-1472. https://doi.org/10.1001/jama.2013.278787
  30. Holcomb CN, Graham LA, Richman JS, et al. The incremental risk of coronary stents on postoperative adverse events: a matched cohort study. Ann Surg 2016;263:924-930. https://doi.org/10.1097/SLA.0000000000001246
  31. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213-260. https://doi.org/10.1093/eurheartj/ehx419
  32. Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008;168:63-69. https://doi.org/10.1001/archinternmed.2007.23
  33. Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology 2003;61:964-968.
  34. Douketis JD, Spyropoulos AC, Murad MH, et al. Perioperative management of antithrombotic therapy: an American College of Chest Physicians Clinical Practice Guideline. Chest 2022;162:e207-e243. https://doi.org/10.1016/j.chest.2022.07.025
  35. Wexner SD, Garbus JE, Singh JJ, et al. A prospective analysis of 13,580 colonoscopies: reevaluation of credentialing guidelines. Surg Endosc 2001;15:251-261. https://doi.org/10.1007/s004640080147
  36. Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc 2001;53:620-627. https://doi.org/10.1067/mge.2001.114422
  37. Ono S, Fujishiro M, Hirano K, et al. Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopy. J Gastroenterol 2009;44:1185-1189. https://doi.org/10.1007/s00535-009-0127-6
  38. Ono S, Fujishiro M, Kodashima S, et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J Gastroenterol 2012;47:770-774. https://doi.org/10.1007/s00535-012-0538-7
  39. Whitson MJ, Dikman AE, von Althann C, et al. Is gastroduodenal biopsy safe in patients receiving aspirin and clopidogrel?: a prospective, randomized study involving 630 biopsies. J Clin Gastroenterol 2011;45:228-233. https://doi.org/10.1097/MCG.0b013e3181eb5efd
  40. Gweon TG, Yang DH. Management of complications related to colorectal endoscopic submucosal dissection. Clin Endosc 2023;56:423-432. https://doi.org/10.5946/ce.2023.104
  41. Uozumi T, Abe S, Makiguchi ME, et al. Complications of endoscopic resection in the upper gastrointestinal tract. Clin Endosc 2023;56:409-422. https://doi.org/10.5946/ce.2023.024
  42. Suwa T, Takizawa K, Kawata N, et al. Current treatment strategy for superficial nonampullary duodenal epithelial tumors. Clin Endosc 2022;55:15-21. https://doi.org/10.5946/ce.2021.141
  43. Cho SJ, Choi IJ, Kim CG, et al. Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy 2012;44:114-121. https://doi.org/10.1055/s-0031-1291459
  44. Miura Y, Tsuji Y, Yoshio T, et al. Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. Gastrointest Endosc 2023;97:889-897. https://doi.org/10.1016/j.gie.2022.12.025
  45. Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest Endosc 2012;75:719-727. https://doi.org/10.1016/j.gie.2011.11.034
  46. Sanomura Y, Oka S, Tanaka S, et al. Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer 2014;17:489-496. https://doi.org/10.1007/s10120-013-0305-3
  47. Matsumura T, Arai M, Maruoka D, et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol 2014;14:172.
  48. Tounou S, Morita Y, Hosono T. Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy. Endosc Int Open 2015;3:E31-E38. https://doi.org/10.1055/s-0034-1390764
  49. Igarashi K, Takizawa K, Kakushima N, et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection? Surg Endosc 2017;31:1746-1753. https://doi.org/10.1007/s00464-016-5167-4
  50. Harada H, Suehiro S, Murakami D, et al. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy. World J Gastroenterol 2019;25:457-468. https://doi.org/10.3748/wjg.v25.i4.457
  51. Park SH, Park SK, Yang HJ, et al. Risk of post-polypectomy bleeding after endoscopic mucosal resection in patients receiving antiplatelet medication: comparison between the continue and hold groups. Surg Endosc 2022;36:6410-6418. https://doi.org/10.1007/s00464-021-08987-w
  52. Yao CC, Chiu YC, Wu KL, et al. The effect of discontinuation of aspirin on colonoscopic postpolypectomy bleeding. Adv Dig Med 2020;7:14-21. https://doi.org/10.1002/aid2.13141
  53. Li YK, Guo CG, Cheung KS, et al. Risk of postcolonoscopy thromboembolic events: a real-world cohort study. Clin Gastroenterol Hepatol 2023;21:3051-3059.
  54. Vranckx P, Valgimigli M, Juni P, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 2018;392:940-949. https://doi.org/10.1016/S0140-6736(18)31858-0
  55. Watanabe H, Domei T, Morimoto T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA 2019;321:2414-2427. https://doi.org/10.1001/jama.2019.8145
  56. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021;52:e364-e467. https://doi.org/10.1161/STR.0000000000000375
  57. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e726-e779. https://doi.org/10.1161/CIR.0000000000000502
  58. Vu CK, Korman MG, Bejer I, Davis S. Gastrointestinal bleeding after cold biopsy. Am J Gastroenterol 1998;93:1141-1143. https://doi.org/10.1111/j.1572-0241.1998.346_e.x
  59. Yabe K, Horiuchi A, Kudo T, et al. Risk of gastrointestinal endoscopic procedure-related bleeding in patients with or without continued antithrombotic therapy. Dig Dis Sci 2021;66:1548-1555. https://doi.org/10.1007/s10620-020-06393-1
  60. Chan FK, Kyaw MH, Hsiang JC, et al. Risk of postpolypectomy bleeding with uninterrupted clopidogrel therapy in an industry-independent, double-blind, randomized trial. Gastroenterology 2019;156:918-925. https://doi.org/10.1053/j.gastro.2018.10.036
  61. Ket S, Hewett DG, Kheir AO, et al. Cold snare polypectomy of colorectal polyps ≤1__mm on clopidogrel: Australian and New Zealand randomized controlled trial. Endosc Int Open 2022;10:E745-E752. https://doi.org/10.1055/a-1813-1019
  62. Bozkurt H, Sert OZ, Olmez T, et al. The risk of post-polypectomy bleeding among patients receiving antithrombotic agents: a prospective observational study. Sao Paulo Med J 2021;139:218-225. https://doi.org/10.1590/1516-3180.2020.0305.r1.10122020
  63. de Benito Sanz M, Hernandez L, Garcia Martinez MI, et al. Efficacy and safety of cold versus hot snare polypectomy for small (5-9 mm) color ectal polyps: a multicenter randomized controlled trial. Endoscopy 2022;54:35-44. https://doi.org/10.1055/a-1327-8357
  64. Pedersen IB, Rawa-Golebiewska A, Calderwood AH, et al. Complete polyp resection with cold snare versus hot snare polypectomy for polyps of 4-9 mm: a randomized controlled trial. Endoscopy 2022;54:961-969. https://doi.org/10.1055/a-1734-7952
  65. Kono Y, Obayashi Y, Baba Y, et al. Postoperative bleeding risk after gastric endoscopic submucosal dissection during antithrombotic drug therapy. J Gastroenterol Hepatol 2018;33:453-460. https://doi.org/10.1111/jgh.13872
  66. Arimoto J, Higurashi T, Chiba H, et al. Continued use of a single antiplatelet agent does not increase the risk of delayed bleeding after colorectal endoscopic submucosal dissection. Dig Dis Sci 2018;63:218-227. https://doi.org/10.1007/s10620-017-4843-0
  67. Hamada T, Yasunaga H, Nakai Y, et al. Bleeding after endoscopic sphincterotomy or papillary balloon dilation among users of antithrombotic agents. Endoscopy 2015;47:997-1004. https://doi.org/10.1055/s-0034-1392408
  68. Eisenberg MJ, Richard PR, Libersan D, et al. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009;119:1634-1642. https://doi.org/10.1161/CIRCULATIONAHA.108.813667
  69. Angiolillo DJ, Firstenberg MS, Price MJ, et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012;307:265-274. https://doi.org/10.1001/jama.2011.2002
  70. Won D, Kim JS, Ji JS, et al. Cold snare polypectomy in patients taking dual antiplatelet therapy: a randomized trial of discontinuation of thienopyridines. Clin Transl Gastroenterol 2019;10:e00091.
  71. Oh S, Kim SG, Kim J, et al. Continuous use of thienopyridine may be as safe as low-dose aspirin in endoscopic resection of gastric tumors. Gut Liver 2018;12:393-401. https://doi.org/10.5009/gnl17384
  72. Furuhata T, Kaise M, Hoteya S, et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy. Gastric Cancer 2017;20:207-214. https://doi.org/10.1007/s10120-015-0588-7
  73. Bhattacharya A, Nelson A, Hoscheit M, et al. Rate of bleeding on antiplatelet and anticoagulant agents in patients undergoing single balloon enteroscopy. Gastrointest Endosc 2018;87(6 Supplement):AB401-AB402. https://doi.org/10.1016/j.gie.2018.04.1874
  74. Nagata N, Yasunaga H, Matsui H, et al. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis. Gut 2018;67:1805-1812. https://doi.org/10.1136/gutjnl-2017-313999
  75. Foote A, Haymart B, Kong X, et al. Interruption of warfarin for lowrisk procedures. J Thromb Thrombolysis 2019;47:607.
  76. Hakuta R, Kogure H, Nakai Y, et al. Endoscopic papillary large balloon dilation without sphincterotomy for users of antithrombotic agents: a multicenter retrospective study. Dig Endosc 2019;31:316-322. https://doi.org/10.1111/den.13326
  77. Bozkurt H, Olmez T, Bulut CI, et al. The safety of upper gastrointestinal endoscopic biopsy in patients receiving antithrombic drugs: a single-centre prospective observational study. Prz Gastroenterol 2020;15:234-240. https://doi.org/10.5114/pg.2019.88622
  78. Zaver HB, Ghoz H, Stancampiano F, et al. Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy. Endosc Int Open 2021;9:E1397-E1403. https://doi.org/10.1055/a-1499-6988
  79. Takeuchi Y, Mabe K, Shimodate Y, et al. Continuous anticoagulation and cold snare polypectomy versus heparin bridging and hot snare polypectomy in patients on anticoagulants with subcentimeter polyps: a randomized controlled trial. Ann Intern Med 2019;171:229-237. https://doi.org/10.7326/M19-0026
  80. Lin D, Soetikno RM, McQuaid K, et al. Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications. Gastrointest Endosc 2018;87:1106-1113. https://doi.org/10.1016/j.gie.2017.11.024
  81. Kishida Y, Hotta K, Imai K, et al. Risk analysis of colorectal post-polypectomy bleeding due to antithrombotic agent. Digestion 2019;99:148-156. https://doi.org/10.1159/000490791
  82. Makino T, Horiuchi A, Kajiyama M, et al. Delayed bleeding following cold snare polypectomy for small colorectal polyps in patients taking antithrombotic agents. J Clin Gastroenterol 2018;52:502-507. https://doi.org/10.1097/MCG.0000000000000802
  83. Matsumoto M, Yoshii S, Shigesawa T, et al. Safety of cold polypectomy for colorectal polyps in patients on antithrombotic medication. Digestion 2018;97:76-81. https://doi.org/10.1159/000484219
  84. Yanagisawa N, Nagata N, Watanabe K, et al. Post-polypectomy bleeding and thromboembolism risks associated with warfarin vs direct oral anticoagulants. World J Gastroenterol 2018;24:1540-1549. https://doi.org/10.3748/wjg.v24.i14.1540
  85. Shimodate Y, Mizuno M, Matsueda K, et al. Is it safe to continue warfarin or to shorten interruption of DOACS in hot-snare polypectomy? Gastrointest Endosc 2019;89(6 Supplement):AB437-AB438. https://doi.org/10.1016/j.gie.2019.03.1233
  86. Ono S, Ishikawa M, Matsuda K, et al. Clinical impact of the perioperative management of oral anticoagulants in bleeding after colonic endoscopic mucosal resection. BMC Gastroenterol 2019;19:206.
  87. Polmanee P, Hara K, Mizuno N, et al. Outcomes of EUS-FNA in patients receiving antithrombotic therapy. Endosc Int Open 2019;7:E15-E25. https://doi.org/10.1055/a-0735-9107
  88. Yu JX, Oliver M, Lin J, et al. Patients prescribed direct-acting oral anticoagulants have low risk of postpolypectomy complications. Clin Gastroenterol Hepatol 2019;17:2000-2007.
  89. Tsoi A, Garg M, Butt J. Post-colonic polypectomy bleeding in patients on anticoagulation therapy. J Gastroenterol Hepatol 2020;35:232-232.
  90. Harada H, Nakahara R, Murakami D, et al. The effect of anticoagulants on delayed bleeding after colorectal endoscopic submucosal dissection. Surg Endosc 2020;34:3330-3337. https://doi.org/10.1007/s00464-019-07101-5
  91. Kishino T, Oyama T, Hotta K, et al. Risk of colonoscopic post-polypectomy bleeding in patients after the discontinuation of antithrombotic therapy. Turk J Gastroenterol 2020;31:752-759. https://doi.org/10.5152/tjg.2020.19428
  92. Muro S, Kato H, Ishida E, et al. Comparison of anticoagulants and risk factors for bleeding following endoscopic sphincterotomy among anticoagulant users: results from a large multicenter retrospective study. J Gastroenterol Hepatol 2020;35:37-42. https://doi.org/10.1111/jgh.14764
  93. Rebello D, Bakhit M, McCarty TR, et al. Heparin bridge is associated with more post-polypectomy bleeding and emergency department visits among anticoagulated patients. Ann Gastroenterol 2020;33:73-79.
  94. Inagaki K, Yamashita K, Oka S, et al. Risk of bleeding after colorectal endoscopic resection in patients with continued warfarin use compared to heparin replacement: a propensity score matching analysis. Gastroenterol Res Pract 2021;2021:9415387.
  95. Kobayashi T, Takeuchi M, Hojo Y, et al. Risk of delayed bleeding after hot snare polypectomy and endoscopic mucosal resection in the colorectum with continuation of anticoagulants. J Gastrointest Oncol 2021;12:1518-1530. https://doi.org/10.21037/jgo-21-3
  96. Kubo K, Kato M, Mabe K, et al. Risk factors for delayed bleeding after therapeutic gastrointestinal endoscopy in patients receiving oral anticoagulants: a multicenter retrospective study. Digestion 2021;102:161-169. https://doi.org/10.1159/000502952
  97. Okuno N, Hara K, Mizuno N, et al. Outcomes of endoscopic ultrasound-guided biliary drainage in patients undergoing antithrombotic therapy. Clin Endosc 2021;54:596-602. https://doi.org/10.5946/ce.2020.194
  98. Terasaki K, Dohi O, Naito Y, et al. Effects of guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment on postoperative bleeding after endoscopic submucosal dissection for early gastric cancer: a propensity score-matching analysis. Digestion 2021;102:256-264. https://doi.org/10.1159/000504597
  99. Thosani N, Rashtak S, Kannadath BS, et al. Bleeding risk and mortality associated with uninterrupted antithrombotic therapy during percutaneous endoscopic gastrostomy tube placement. Am J Gastroenterol 2021;116:1868-1875. https://doi.org/10.14309/ajg.0000000000001348
  100. Yan Z, Gao F, Xie J, et al. Incidence and risk factors of colorectal delayed post-polypectomy bleeding in patients taking antithrombotics. J Dig Dis 2021;22:481-487. https://doi.org/10.1111/1751-2980.13034
  101. Yuki T, Ishihara S, Yashima K, et al. Bleeding risk related to upper gastrointestinal endoscopic biopsy in patients receiving antithrombotic therapy: a multicenter prospective observational study. Curr Ther Res Clin Exp 2017;84:32-36. https://doi.org/10.1016/j.curtheres.2017.03.006
  102. Ara N, Iijima K, Maejima R, et al. Prospective analysis of risk for bleeding after endoscopic biopsy without cessation of antithrombotics in Japan. Dig Endosc 2015;27:458-464. https://doi.org/10.1111/den.12407
  103. Morita A, Horiuchi I, Tanaka N, et al. Managing bleeding risk after cold snare polypectomy in patients receiving direct-acting oral anticoagulants. Gastrointest Endosc 2022;95:969-974. https://doi.org/10.1016/j.gie.2022.01.005
  104. Radaelli F, Fuccio L, Paggi S, et al. Periendoscopic management of direct oral anticoagulants: a prospective cohort study. Gut 2019;68:969-976.
  105. Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 2019;179:1469-1478. https://doi.org/10.1001/jamainternmed.2019.2431
  106. Tomida H, Yoshio T, Igarashi K, et al. Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric Cancer 2021;24:179-189. https://doi.org/10.1007/s10120-020-01105-0
  107. Masuda S, Koizumi K, Nishino T, et al. Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: a retrospective study. BMC Gastroenterol 2021;21:401.
  108. Jung BC, Kim NH, Nam GB, et al. The Korean Heart Rhythm Society's 2014 statement on antithrombotic therapy for patients with nonvalvular atrial fibrillation: Korean Heart Rhythm Society. Korean Circ J 2015;45:9-19. https://doi.org/10.4070/kcj.2015.45.1.9
  109. Kim HK, Tantry US, Smith SC Jr, et al. The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost 2021;121:422-432. https://doi.org/10.1055/s-0040-1718729